For decades, diseases like sickle cell disease and severe beta-thalassemia were viewed as lifelong genetic conditions that patients simply had to live with. Today, that reality is beginning to change. At the centre of one of the world’s biggest medical breakthroughs is Dr Swee Lay Thein, a Malaysian-born scientist from Kuantan whose research is now helping transform the future of medicine.
Dr Swee Lay Thein has officially become the first Malaysian-born scientist to win the prestigious Breakthrough Prize in Life Sciences, often known globally as the “Oscars of Science”.
The award, valued at US$3 million (around RM12 million), recognised her groundbreaking work in helping make the world’s first approved CRISPR gene-editing therapy possible.
For many Malaysians, this may be the first time hearing her name. But within the global scientific and medical community, Dr Swee Lay Thein has long been regarded as one of the leading experts in genetic blood disorder research.
Her discoveries are now helping open the door to what many believe could become one of the most important revolutions in modern medicine.
How Dr Swee Lay Thein Helped Change The Future Of Genetic Medicine
Dr Swee Lay Thein, who currently serves as chief and senior investigator of the Sickle Cell Branch at the U.S. National Heart, Lung and Blood Institute, shared the prestigious award with Stuart H. Orkin from Harvard Medical School.
She was recognised for discovering the gene B-cell lymphoma/leukaemia 11A (BCL11A), which was identified as a key regulator of fetal haemoglobin production.
Prof Orkin also separately discovered the gene and later demonstrated how it acts as a biological “switch” that controls the transition from fetal to adult haemoglobin as children grow older.
Together, their discoveries laid the scientific foundation for Casgevy, the world’s first approved CRISPR gene-editing therapy for sickle cell disease and severe beta-thalassemia, two inherited blood disorders that affect an estimated nine million people worldwide.
The therapy works by reactivating fetal haemoglobin, a form of haemoglobin naturally present before birth that does not trigger the dangerous cell damage associated with these disorders.
By blocking the BCL11A switch, scientists found a way to allow fetal haemoglobin to be produced again, helping patients generate healthier blood cells and significantly reducing severe complications linked to the disease.
What makes this breakthrough especially significant is that it goes beyond simply managing symptoms.
Instead, it brings modern medicine closer towards something far more powerful, a functional cure for genetic blood disorders that were once considered lifelong conditions.
From Kuantan To Global Recognition
Born in Kuantan in 1952, Dr Swee Lay Thein began her journey far away from the laboratories and international award ceremonies she is recognised at today.
She studied medicine at the University of Malaya before continuing her research career in the United Kingdom and later the United States.
Her scientific journey was shaped by years of studying why some patients with severe blood disorders surprisingly experienced milder symptoms than others.
That curiosity eventually led to discoveries now transforming the treatment of inherited blood diseases around the world.
Early in her career, Dr Swee Lay Thein trained under renowned physician-scientist David Weatherall at the University of Oxford, where she began exploring the genetic mechanisms behind blood disorders and haemoglobin production.
Today, Dr Swee Lay Thein continues leading major global research programmes focused on sickle cell disease while also mentoring scientists across Africa and Asia. She also hosts the international Sickle Cell in Focus conference, which brings together leading researchers and medical experts from around the world.
In 2024, Dr Swee Lay Thein and Prof Stuart H. Orkin jointly received the prestigious Shaw Prize in Life Science and Medicine for the same groundbreaking discovery involving the BCL11A gene and fetal haemoglobin regulation.
Dr Swee Lay Thein Hopes To Inspire Young Malaysians
Despite receiving one of the world’s highest honours in science, Dr Swee Lay Thein spoke with humility and gratitude about the recognition.
“To be the first Malaysian to receive this recognition is not just a personal milestone. It belongs to everyone who believed in me, mentored me and to the country that shaped me,” she said.
“I hope it will send a message to young people in Malaysia and across South-East Asia that their background does not define what they can achieve.
“Only their dedication and hunger to ask the next question does.”
Today, Dr Swee Lay Thein’s work is regarded as one of the most important breakthroughs in modern medical science, helping pave the way for treatments that could improve the lives of millions of patients worldwide suffering from genetic blood disorders.
Beyond the prestigious awards, scientific recognition, and global headlines, her journey represents something even more meaningful.
It is the story of how curiosity, persistence, education, and years of dedication can take someone from a modest upbringing in Malaysia to the forefront of world-changing scientific discovery.
Sources: 1| 2| 3
Related articles:
Prof Norazah Among the World’s Top 2% Scientists, Seven Years in a Row
She Left Academia to Start Dr Anne Skincare, Now It’s Leading the Industry
Discussion about this post